| HOME >> BIOLOGY >> TECHNOLOGY |
3.4 Rest of World
3.4.1 Israel
4. ANNEXURE 4.1 Research methodology
4.2 The Questionnaire
4.3 Feedback </
Charts & GraphsGLOBAL MARKET PERSPECTIVE
Chart 1: Primary Areas of Guidance in Considering Molecular Imaging as a Cancer Biomarker
Chart 2: The Classes of Biomarkers as Defined by FDA Pharmacogenomics Guidelines
Chart 3: Global Biomarkers Market Analysis (2007-2015) in USD Million
Chart 4: Global Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Molecular Imaging, Proteomics and Other in USD Million
Chart 5: Glance at 2007, 2010 and 2015 Global Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Molecular Imaging, Proteomics and Other
Chart 6: Global Biomarkers Market Analysis (2007-2015) by Therapeutic Area – Cardiology, Neurology, Oncology and Other in USD Million
Chart 7: Glance at 2007, 2010 and 2015 Global Biomarkers Market Share (%) by Therapeutic Area – Cardiology, Neurology, Oncology and Other
Chart 8: Global Bioinformatics Market Analysis (2007-2015) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD Million
Chart 9: Glance at 2007, 2010 and 2015 Global Bioinformatics Market Share (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World
Chart 10: Global Genomics Market Analysis (2007-2015) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD Million
Chart 11: Glance at 2007, 2010 and 2015 Global Genomics Market Share (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World
Chart 12: Global Molecular Imaging Market Analysis (2007-2015) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD Million
Chart 13: Glance at 2007, 2010 and 2015
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |